Healthcare Services Group, Inc.
NASDAQ:HCSGMedical - Care Facilities
+$0.39 today
- Market cap
- $1.69B
- Beta
- 0.83
- P/E (TTM)
- 23.4
- EPS (TTM)
- $0.97
Volume 0.62M
Average 0.69M
HCSG EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Healthcare Services Group, Inc.NASDAQ: HCSG
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA growth accelerates
Q1 FY2026 EBITDA of $38.35M rose 36.1% year over year, ahead of the +28.0% change in trailing-twelve-month EBITDA. Sequentially, it rose 16.9% from the prior quarter. Over 3 fiscal years it compounded at +11.1% a year.
Context
- EBITDA amounted to 4.7% of revenue in FY2025, up 0.4 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 5 analysts of $146.87M (+70.3%) for the fiscal year ending Dec 2026, a step up from the +16.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $38.35M+16.9% QoQ
- Last fiscal yearDec 2025
- $86.22M+16.6% YoY
- LTMMar 2026
- $96.4M+28.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +36.1% | +165.1% | +129.0 pp |
| 1 year | +16.6% | +70.3% | +53.8 pp |
| 3-year CAGR | +11.1% | +21.6% | +10.5 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 86.22M USD
- Year-over-year change
- +16.6%
- 4-year CAGR
- +1.4%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 86.22M | +16.6% |
| FY2024 | 2024-12-31 | 73.96M | -1.7% |
| FY2023 | 2023-12-31 | 75.26M | +19.7% |
| FY2022 | 2022-12-31 | 62.86M | -22.9% |
| FY2021 | 2021-12-31 | 81.56M | — |
EBITDA vs competitors
How HCSG compares with its peers on the latest reported figures
- HCSG's LTM Mar 2026 EBITDA of $96.4M is the 7th highest of the 11 companies compared; the peer median is $104.34M.
- Its year-over-year change of +28.0% is the 3rd highest of 11, against a peer median of -12.1%.
- EBITDA amounts to 5.2% of revenue for HCSG, versus a peer median of 12.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $518.25M | +57.7% | -5.8% | 9.4% | |
| LTM Apr 2026 | $462.48M | -25.4% | -7.2% | 16.2% | |
| LTM Mar 2026 | $173.34M | +1.2% | +41.4% | 22.0% | |
| LTM Mar 2026 | $169.63M | -31.6% | +170.6% | 12.4% | |
| LTM Aug 2026 | $105.13M | +112.0% | +9.9% | 11.9% | |
| LTM Mar 2026 | $103.54M | +13.1% | +13.0% | 14.2% | |
| LTM Mar 2026 | $96.4M | +28.0% | +11.1% | 5.2% | |
| LTM Mar 2026 | $60.01M | +22.5% | +51.2% | 5.9% | |
| LTM Mar 2026 | -$42.13M | -107.6% | — | 7.1% | |
| LTM Jan 2026 | -$128M | -87.3% | — | 152.9% | |
| LTM Mar 2026 | -$408.44M | -151.5% | — | — | |
| Peer median (excluding HCSG) | $104.34M | -12.1% | +13.0% | 12.4% | |
Competitors are the stored peer set for HCSG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.64B | 1.69B | 1.67B | 1.72B | 1.84B |
| Cost of Revenue | 1.41B | 1.5B | 1.46B | 1.49B | 1.6B |
| Gross Profit | 230.57M | 193.31M | 214.75M | 228.09M | 239.41M |
| Gross Margin | 14.0% | 11.4% | 12.8% | 13.3% | 13.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 166.43M | 149.52M | 160.09M | 174.82M | 190.87M |
| Operating Expenses | 166.43M | 149.52M | 160.09M | 174.82M | 190.87M |
| Depreciation & Amortization | 14.67M | 15.32M | 14.34M | 14.59M | 16.78M |
| EBITDA | 81.56M | 62.86M | 75.26M | 73.96M | 86.22M |
| EBITDA Margin | 5.0% | 3.7% | 4.5% | 4.3% | 4.7% |
| Operating Income | 64.13M | 43.79M | 54.66M | 53.27M | 48.54M |
| Operating Margin | 3.9% | 2.6% | 3.3% | 3.1% | 2.6% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.39M | 2.99M | 7.86M | 6.44M | 1.58M |
| Other Income / Expenses | 1.38M | 764K | (1.6M) | (330K) | 19.33M |
| Income Before Tax | 65.51M | 44.55M | 53.06M | 52.94M | 67.87M |
| Pre-Tax Margin | 4.0% | 2.6% | 3.2% | 3.1% | 3.7% |
| Income Tax Expense | 16.97M | 10.31M | 14.67M | 13.47M | 8.81M |
| Net Income | 48.54M | 34.24M | 38.39M | 39.47M | 59.06M |
| Net Margin | 3.0% | 2.0% | 2.3% | 2.3% | 3.2% |
| EPS (Basic) | 0.65 | 0.46 | 0.52 | 0.54 | 0.82 |
| EPS (Diluted) | 0.65 | 0.46 | 0.52 | 0.53 | 0.81 |
| Weighted Avg Shares | 74.82M | 74.34M | 74.29M | 73.75M | 72.38M |
| Weighted Avg Shares (Diluted) | 74.96M | 74.35M | 74.34M | 73.99M | 73.03M |
Healthcare Services Group, Inc.
NASDAQ:HCSG
Intrinsic Alpha fair value
Locked
Current Price
$25.10
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.